Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

These glasses allow people with macular degeneration to see complete objects by banishing pesky blind spots using dozens of ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

Age-related macular degeneration (AMD ... As of 2023, the only FDA-approved treatments for dry AMD are two injectable drugs. These treatments are constrained by potential complications from ...

Izervay (avacincaptad pegol) is a prescription injection used to treat severe age-related macular degeneration (AMD ... side effects during Izervay treatment. Examples of the drug’s commonly ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion. Age-related macular degeneration (AMD ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

In the last 20 years, there have been rapid advances in the treatment options for myopic ... it is possible that patients with myopic macular degeneration complicated by CNV may benefit from ...

On completion of the scans and tests, he said: “You have early age-related macular degeneration ... the sound of a voice to recognise who was there.